Status:
COMPLETED
Evaluation of Depolarization and Repolarisation Activity During Cardiac Arrhythmia Using a Novel Monophasic Action Potential Catheter
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Atrial Fibrillation
Ventricular Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Monophasic action potential (MAP) recording plays an important role in a more direct view of human myocardial electrophysiology under both physiological and pathological conditions. The MAP method rep...
Detailed Description
This is a prospective descriptive study including 1 French centre The arrhythmogenic substrate that leads to fibrillating heart is poorly understood. This has hindered the development of methods for b...
Eligibility Criteria
Inclusion
- Patients with Atrial Fibrillation or Ventricular Fibrillation or junctional tachycardia or reentrant tachycardia
- Age ≥ 18 years old
- Signed patient informed consent form
- Affiliated to social security (European countries)
Exclusion
- Patients under 18 years old
- Pregnancy
- Psychiatric disorders
- Neurological sequelae after a prior cardiac arrest that prevents informed consent
- Absence of informed consent form
Key Trial Info
Start Date :
January 17 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 12 2016
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT01254474
Start Date
January 17 2011
End Date
April 12 2016
Last Update
February 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital cardiologique du Haut-Lévêque, Cardiac arrhythmias department
Pessac, France, 33604